Related Experiment Video
Updated: Jun 28, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
[Hazard, risk and harm in clinical trials]
Abstract:
Investigators and other stakeholders involved in clinical trials are not aware about all possible harms, hazards and risks related to this activity. Different categories of harms may occur during clinical trials like: physical (injury, illness, pain, suffering, or discomfort), psychological, social, economic, legal, dignitary and relational. Clinical trial participants are not the only one stakeholder exposed to different types of hazards. Among others the most important are: investigators, sponsors, centers (where clinical trials are conducted), contract research organizations and bioethics committees. Regardless of multiple hazards, substantial harms are discovered relatively rare. This situation could be explained by a small number of high risk potential clinical trials and low social awareness about different types of possible harms. Proper education should ameliorate our knowledge about hazards, risks and harms in clinical trials.
Related Concept Videos
Hazard Ratio
For example, in a clinical trial evaluating a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Hazard Rate
Clinical Trials: Overview
Preclinical Development: Overview
